Martin P Paulus1, Quentin J M Huys2, Tiago V Maia3. 1. Laureate Institute for Brain Research, Tulsa, OK; Psychiatry, University of California San Diego, La Jolla, CA. 2. Translational Neuromodeling Unit, Institute for Biomedical Engineering, University of Zurich and Swiss Federal Institute of Technology (ETH) Zurich, Switzerland; Centre for Addictive Disorders, Department of Psychiatry, Psychotherapy and Psychosomatics, Hospital of Psychiatry, University of Zurich, Switzerland. 3. Institute for Molecular Medicine, School of Medicine, University of Lisbon, Portugal.
Abstract
BACKGROUND: Computational psychiatry is a burgeoning field that utilizes mathematical approaches to investigate psychiatric disorders, derive quantitative predictions, and integrate data across multiple levels of description. Computational psychiatry has already led to many new insights into the neurobehavioral mechanisms that underlie several psychiatric disorders, but its usefulness from a clinical standpoint is only now starting to be considered. METHODS: Examples of computational psychiatry are highlighted, and a phase-based pipeline for the development of clinical computational-psychiatry applications is proposed, similar to the phase-based pipeline used in drug development. It is proposed that each phase has unique endpoints and deliverables, which will be important milestones to move tasks, procedures, computational models, and algorithms from the laboratory to clinical practice. RESULTS: Application of computational approaches should be tested on healthy volunteers in Phase I, transitioned to target populations in Phase IB and Phase IIA, and thoroughly evaluated using randomized clinical trials in Phase IIB and Phase III. Successful completion of these phases should be the basis of determining whether computational models are useful tools for prognosis, diagnosis, or treatment of psychiatric patients. CONCLUSIONS: A new type of infrastructure will be necessary to implement the proposed pipeline. This infrastructure should consist of groups of investigators with diverse backgrounds collaborating to make computational psychiatry relevant for the clinic.
BACKGROUND: Computational psychiatry is a burgeoning field that utilizes mathematical approaches to investigate psychiatric disorders, derive quantitative predictions, and integrate data across multiple levels of description. Computational psychiatry has already led to many new insights into the neurobehavioral mechanisms that underlie several psychiatric disorders, but its usefulness from a clinical standpoint is only now starting to be considered. METHODS: Examples of computational psychiatry are highlighted, and a phase-based pipeline for the development of clinical computational-psychiatry applications is proposed, similar to the phase-based pipeline used in drug development. It is proposed that each phase has unique endpoints and deliverables, which will be important milestones to move tasks, procedures, computational models, and algorithms from the laboratory to clinical practice. RESULTS: Application of computational approaches should be tested on healthy volunteers in Phase I, transitioned to target populations in Phase IB and Phase IIA, and thoroughly evaluated using randomized clinical trials in Phase IIB and Phase III. Successful completion of these phases should be the basis of determining whether computational models are useful tools for prognosis, diagnosis, or treatment of psychiatricpatients. CONCLUSIONS: A new type of infrastructure will be necessary to implement the proposed pipeline. This infrastructure should consist of groups of investigators with diverse backgrounds collaborating to make computational psychiatry relevant for the clinic.
Authors: Patrick M Bossuyt; Johannes B Reitsma; David E Bruns; Constantine A Gatsonis; Paul P Glasziou; Les M Irwig; David Moher; Drummond Rennie; Henrica C W de Vet; Jeroen G Lijmer Journal: Ann Intern Med Date: 2003-01-07 Impact factor: 25.391
Authors: Susan M Czajkowski; Lynda H Powell; Nancy Adler; Sylvie Naar-King; Kim D Reynolds; Christine M Hunter; Barbara Laraia; Deborah H Olster; Frank M Perna; Janey C Peterson; Elissa Epel; Josephine E Boyington; Mary E Charlson Journal: Health Psychol Date: 2015-02-02 Impact factor: 4.267
Authors: J Schrouff; M J Rosa; J M Rondina; A F Marquand; C Chu; J Ashburner; C Phillips; J Richiardi; J Mourão-Miranda Journal: Neuroinformatics Date: 2013-07
Authors: Miriam Sebold; Lorenz Deserno; Stephan Nebe; Stefan Nebe; Daniel J Schad; Maria Garbusow; Claudia Hägele; Jürgen Keller; Elisabeth Jünger; Norbert Kathmann; Michael N Smolka; Michael Smolka; Michael A Rapp; Florian Schlagenhauf; Andreas Heinz; Quentin J M Huys Journal: Neuropsychobiology Date: 2014-10-30 Impact factor: 2.328
Authors: Klaas E Stephan; Dominik R Bach; Paul C Fletcher; Jonathan Flint; Michael J Frank; Karl J Friston; Andreas Heinz; Quentin J M Huys; Michael J Owen; Elisabeth B Binder; Peter Dayan; Eve C Johnstone; Andreas Meyer-Lindenberg; P Read Montague; Ulrich Schnyder; Xiao-Jing Wang; Michael Breakspear Journal: Lancet Psychiatry Date: 2015-11-11 Impact factor: 27.083
Authors: V Voon; K Baek; J Enander; Y Worbe; L S Morris; N A Harrison; T W Robbins; C Rück; N Daw Journal: Transl Psychiatry Date: 2015-11-03 Impact factor: 6.222
Authors: Nikolaos Koutsouleris; Lana Kambeitz-Ilankovic; Stephan Ruhrmann; Marlene Rosen; Anne Ruef; Dominic B Dwyer; Marco Paolini; Katharine Chisholm; Joseph Kambeitz; Theresa Haidl; André Schmidt; John Gillam; Frauke Schultze-Lutter; Peter Falkai; Maximilian Reiser; Anita Riecher-Rössler; Rachel Upthegrove; Jarmo Hietala; Raimo K R Salokangas; Christos Pantelis; Eva Meisenzahl; Stephen J Wood; Dirk Beque; Paolo Brambilla; Stefan Borgwardt Journal: JAMA Psychiatry Date: 2018-11-01 Impact factor: 21.596
Authors: Amanda B Zheutlin; Adam M Chekroud; Renato Polimanti; Joel Gelernter; Fred W Sabb; Robert M Bilder; Nelson Freimer; Edythe D London; Christina M Hultman; Tyrone D Cannon Journal: Schizophr Bull Date: 2018-08-20 Impact factor: 9.306
Authors: Joan Luby; Norrina Allen; Ryne Estabrook; Daniel S Pine; Cynthia Rogers; Sheila Krogh-Jespersen; Elizabeth S Norton; Lauren Wakschlag Journal: Behav Res Ther Date: 2019-09-26
Authors: Frederike H Petzschner; Sarah N Garfinkel; Martin P Paulus; Christof Koch; Sahib S Khalsa Journal: Trends Neurosci Date: 2021-01 Impact factor: 13.837